Clinical Trial Update: CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating irinotecan (CPT-11), cisplatin, and celecoxib with radiation therapy in unresectable non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CELEBREX (Celecoxib)
• Camptosar (irinotecan)
• Platinol (cisplatin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lung Cancer | Phase 1 | Status: COMPLETED